sclareol has been researched along with gamma-aminobutyric acid in 1 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
| Studies (sclareol) | Trials (sclareol) | Recent Studies (post-2010) (sclareol) | Studies (gamma-aminobutyric acid) | Trials (gamma-aminobutyric acid) | Recent Studies (post-2010) (gamma-aminobutyric acid) |
|---|---|---|---|---|---|
| 106 | 0 | 70 | 40,215 | 1,423 | 9,631 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, MF; Akbor, MS; Araújo, IM; Bappi, MH; Coutinho, HDM; Elbendary, EY; Gonçalves, SA; Han, H; Islam, MT; Kamli, H; Lho, LH; Prottay, AAS; Raposo, A; Shaikh, A; Sonia, FA | 1 |
1 other study(ies) available for sclareol and gamma-aminobutyric acid
| Article | Year |
|---|---|
Sclareol exerts synergistic antidepressant effects with quercetin and caffeine, possibly suppressing GABAergic transmission in chicks.
Topics: Caffeine; gamma-Aminobutyric Acid; Humans; Quercetin; Receptors, GABA-A | 2023 |